| Edit |   |
|---|
| Product Name | CPI-1205 |
|---|
| Description | Purity ≥98% by HPLC. MW: 518.57. CPI-1205 is a highly potent (biochemical IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of the histone lysine methyltransferase EZH2 (biochemical IC50 = 0.002 μM, cellular EC50 = 0.032 μM). Upon oral administration, CPI-1205 selectively inhibits the activity of both wild-type and mutated forms of EZH2. |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide; CPI1205 |
|---|
| Gene, Accession, CAS # | CAS: 1621862-70-1 |
|---|
| Catalog # | B2509-1 |
|---|
| Price | |
|---|
| Order / More Info | CPI-1205 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|